ciclopirox has been researched along with Carcinoma, Intraductal, Noninfiltrating in 2 studies
Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "DCIS is treated by surgery and possibly radiotherapy." | 1.72 | Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy. ( Al-Zubaydi, F; Chan, N; Gao, D; Holloway, J; Kakkar, D; Kumar, S; Li, S; Love, S; Sabaawy, HE; Sinko, PJ; Szekely, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Zubaydi, F | 2 |
| Gao, D | 2 |
| Kakkar, D | 2 |
| Li, S | 2 |
| Adler, D | 1 |
| Holloway, J | 2 |
| Szekely, Z | 2 |
| Gu, Z | 1 |
| Chan, N | 2 |
| Kumar, S | 2 |
| Love, S | 2 |
| Sinko, PJ | 2 |
| Sabaawy, HE | 1 |
2 other studies available for ciclopirox and Carcinoma, Intraductal, Noninfiltrating
| Article | Year |
|---|---|
Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.
Topics: Animals; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Ciclopirox; Drug Deliver | 2020 |
Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Ciclopiro | 2022 |